Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 05, 2026
HSBC Holdings (HSBC) Delivers +60% Profit Surge in Q2 2026

HSBC Holdings (HSBC) Delivers +60% Profit Surge in Q2 2026

Key Takeaways

  • HSBC reported second-quarter profit before tax of $10.1 billion, a 60% year-over-year surge that comfortably beat the consensus estimate of $9.51 billion.
  • Revenue climbed to $19.1 billion, exceeding analyst forecasts of $18.51 billion, driven by strong wealth management fees and higher net interest income.
  • The bank resumed share buybacks with a $1 billion repurchase program, its first since pausing in October 2025 following the Hang Seng Bank privatization.
  • First-half annualized return on average tangible equity (RoTE) reached 19.1%, well above the bank's full-year target of 17% or better.
  • Full-year banking net interest income (NII) guidance was raised to "at least $46 billion," reflecting an improved interest rate outlook.
  • A second interim dividend of $0.10 per share was approved, underscoring confidence in the bank's capital generation.

Putting the Results in Context

HSBC Holdings' second-quarter and first-half 2026 results, released on August 4, 2026, arrive at a pivotal moment for the London-headquartered global banking giant. The bank is navigating a complex macroeconomic environment shaped by geopolitical tensions in the Middle East, evolving US-China trade dynamics, and shifting interest rate expectations. This earnings report serves as the first major checkpoint since HSBC outlined ambitious medium-term targets in February 2026, including a RoTE of 17% or better through 2028. With the bank's restructuring efforts under Group CEO Georges Elhedery gaining momentum, investors were closely watching whether the simplified four-business structure could deliver consistent growth across all segments while maintaining cost discipline and capital strength. I also checked this using Tickeron’s AI Screener to see how HSBC stacks up against peers in the sector.

Reported Results

HSBC delivered broad-based strength across its global franchise in the second quarter of 2026. Reported profit before tax jumped 60% year-over-year to $10.1 billion, surpassing the analyst consensus of $9.51 billion. The comparison benefited from a favorable swing in notable items — the prior-year quarter included a $2.1 billion charge related to the bank's stake in China's Bank of Communications. Even excluding notable items and currency effects, pre-tax profit rose to $20.4 billion for the first half, up 6% from the same period in 2025.

Revenue for the quarter reached $19.1 billion ($19.12 billion on an adjusted basis), exceeding the $18.51 billion consensus estimate by approximately 3.3%. For the first half, revenue grew 11% year-over-year to $37.7 billion. Banking net interest income (NII), which reflects interest earned on loans minus interest paid on deposits, rose 8% to $22.9 billion in the first half, supported by deposit balance growth and the reinvestment of the bank's structural hedge at higher yields. Net interest margin (NIM), a key measure of lending profitability, improved to 1.61% from 1.57% a year earlier.

Wealth management was a standout performer, with fee and other income in the bank's International Wealth and Premier Banking (IWPB) division growing 21% in the second quarter. Wealth balances reached $1.1 trillion, cementing HSBC's position as the leading wealth manager in Asia. Wholesale transaction banking also posted strong fee growth, supported by higher customer activity, particularly in Hong Kong.

Expected credit losses (ECL), the amount banks set aside for potential loan defaults, totaled $2.4 billion for the first half, up from $2.2 billion a year earlier. The increase reflected charges related to a UK fraud exposure, Hong Kong commercial real estate, and uncertainty linked to the Middle East conflict. On a positive note, the bank's capital position remained robust, with a common equity tier 1 (CET1) ratio — a core measure of financial strength — of 14.1%, within the medium-term target range of 14% to 14.5%. From what I see, the underlying trends here look solid when viewed through the lens of Tickeron’s AI Trend Prediction Engine.

Market Reaction and Investor Sentiment

Despite the strong headline numbers, HSBC's stock reaction was notably muted. Shares slipped 0.37% to $107.46 in early trading on August 4, following a previous close of $107.86, with the Hong Kong-listed shares also trading slightly lower. The subdued price action suggests that much of the positive earnings momentum had already been priced in — the stock had surged approximately 36% year-to-date in Hong Kong, building on a 61% gain in 2025, and was trading near its 52-week high.

Investor sentiment entering the report was broadly optimistic, buoyed by the bank's restructuring progress, easing fears around US-China trade tensions, and consistent execution across all four business units. The resumption of buybacks was a welcome development after a nine-month pause, signaling management's confidence in the capital position. However, the uptick in expected credit losses and ongoing geopolitical uncertainty may temper near-term enthusiasm. The market also appeared to take a measured view of the fact that a significant portion of the profit jump was attributable to the absence of last year's Bank of Communications impairment, rather than purely organic growth.

Forward Outlook and Key Factors to Monitor

HSBC enters the second half of 2026 with strengthened momentum, but investors should watch several key factors that will shape the bank's trajectory through year-end.

Interest Rate Trajectory and NII Sensitivity: The upgrade to full-year banking NII guidance — now "at least $46 billion" versus "around $46 billion" previously — reflects a more favorable rate environment. However, interest rate expectations remain volatile and market-dependent. Any significant shift in central bank policy, particularly from the Federal Reserve or the Bank of England, could impact HSBC's NII and net interest margin in the quarters ahead. The bank's large deposit base and structural hedge provide some insulation, but rate sensitivity remains a critical variable.

Credit Quality and Asset Risks: The rise in ECL charges to an annualized 47 basis points of gross loans in the first half, slightly above the full-year guidance of approximately 45 basis points, warrants close monitoring. Key areas of concern include the Hong Kong commercial real estate sector, where stage 3 charges persisted in Q2, and the broader impact of the Middle East conflict on loan portfolios. Any further deterioration in credit metrics could pressure profitability and investor sentiment.

Wealth Management Growth Trajectory: The wealth division's 21% fee income growth in Q2 underscores the potential of HSBC's Asian wealth franchise. With $1.1 trillion in wealth balances and $64 billion in net new money during the first half, the division is emerging as a powerful earnings engine. Sustaining this momentum will depend on continued customer activity in Hong Kong and mainland China, as well as broader market conditions that influence asset valuations and transaction volumes.

Cost Discipline and Restructuring Progress: HSBC continues to target operating expense growth of approximately 1% for 2026, with organizational simplification savings helping offset inflationary pressures and technology investments. The ability to deliver on this commitment while funding growth initiatives will be a key test of management's execution capabilities. Cost efficiency improvements have already lowered the cost efficiency ratio to 46.2% from 49.9% in the prior-year period, and further progress will support the RoTE target.

Capital Return and Buyback Execution: The $1 billion buyback resumption is a positive signal, but the pace and scale of future capital returns will depend on the CET1 ratio remaining within the 14% to 14.5% target range. With strong capital generation of 190 basis points in the first half, the bank appears well-positioned to sustain shareholder distributions, though regulatory developments and risk-weighted asset growth could influence the cadence of buybacks in subsequent quarters.

Enhancing Research with Tickeron Tools

In my own analysis workflow, I frequently turn to Tickeron’s AI Screener to quickly filter for similar earnings-driven opportunities across global banks and compare key metrics like RoTE, NII growth, and credit trends. It helps surface ideas efficiently without replacing my own judgment, and I’ve found it particularly useful when cross-checking sector performance after reports like this one from HSBC.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: HSBC

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


HSBC's Stochastic Oscillator stays in oversold zone for 2 days

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +2.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where HSBC advanced for three days, in 258 of 374 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

The Aroon Indicator entered an Uptrend today. In 284 of 430 cases where HSBC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.

Bearish Trend Analysis

The 10-day RSI Indicator for HSBC moved out of overbought territory on September 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 54 similar instances where the indicator moved out of overbought territory. In 16 of the 54 cases, the stock moved lower in the following days. This puts the odds of a move lower at 30%.

The Momentum Indicator moved below the 0 level on September 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HSBC as a result. In 32 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 38%.

The Moving Average Convergence Divergence Histogram (MACD) for HSBC turned negative on September 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 18 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 43%.

HSBC moved below its 50-day moving average on September 22, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for HSBC crossed bearishly below the 50-day moving average on September 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 47%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSBC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 46%.

HSBC broke above its upper Bollinger Band on September 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 2 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 20, placing this stock better than average.

The Tickeron SMR rating for this company is 3 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. HSBC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 54 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.756) is normal, around the industry mean (1.887). P/E Ratio (14.421) is within average values for comparable stocks, (15.079). Projected Growth (PEG Ratio) (0.886) is also within normal values, averaging (2.038). HSBC has a moderately high Dividend Yield (0.037) as compared to the industry average of (0.026). P/S Ratio (4.724) is also within normal values, averaging (3.867).

Notable companies

The most notable companies in this group are JPMorgan Chase & Co (NYSE:JPM), Bank of America Corp (NYSE:BAC), HSBC Holdings PLC (NYSE:HSBC), Wells Fargo & Co (NYSE:WFC), Citigroup (NYSE:C), Barclays PLC (NYSE:BCS).

Industry description

Major banks are among the biggest companies in the world, often times with global reach and market capitalizations in the multi-billions. Large banks often have multiple arms spanning different disciplines, from deposits, to investment banking, to wealth management and insurance. The biggest banks often have key competitive advantages over smaller players in the industry in terms of brand recognition, cost of capital, and efficiency. Think J.P. Morgan, Bank of America, Wells Fargo, and Citigroup.

Market Cap

The average market capitalization across the Major Banks Industry is 208.75B. The market cap for tickers in the group ranges from 1.04M to 911.92B. JPM holds the highest valuation in this group at 911.92B. The lowest valued company is BACRP at 1.04M.

High and low price notable news

The average weekly price growth across all stocks in the Major Banks Industry was -3%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 23%. C experienced the highest price growth at 2%, while WFC experienced the biggest fall at -4%.

Volume

The average weekly volume growth across all stocks in the Major Banks Industry was -39%. For the same stocks of the Industry, the average monthly volume growth was 17% and the average quarterly volume growth was -30%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 68
P/E Growth Rating: 32
Price Growth Rating: 44
SMR Rating: 4
Profit Risk Rating: 19
Seasonality Score: -29 (-100 ... +100)
View a ticker or compare two or three
HSBC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a major bank

Industry MajorBanks

Industry
Major Banks
Address
8 Canada Square
Phone
+44 2079918888
Employees
212694
Web
https://www.hsbc.com
Interact to see
Advertisement
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.
Shares of GSAT are surging approximately +15% intraday on March 25, 2026, following a prior session close of $61.09. The primary catalyst is a fresh analyst note from Scotiabank highlighting Globalstar's direct-to-device satellite connectivity bypassing cellular towers — most notably in Mexico — reinforcing the company's next-generation infrastructure thesis.
Shares of ADMA are declining approximately 12% in Wednesday's session, extending a steep two-day selloff. The primary catalyst is a short-seller research report published by Culper Research on March 24, 2026, alleging that ADMA engaged in channel stuffing to artificially inflate revenue growth.
Honeywell International (HON) and TransDigm Group (TDG) are prominent players in the aerospace and industrials sector, benefiting from rising air travel demand, defense spending, and aftermarket services. This stock comparison evaluates their business models, recent performance, and market positioning to help traders and investors assess relative strengths in the current environment. With global aviation recovery and geopolitical tensions supporting sector tailwinds, professionals seeking exposure to aerospace growth versus diversified industrials stability will find these insights relevant for portfolio decisions and relative performance analysis.
PL shares are surging approximately +15% in Wednesday's session, trading near $35.89, pushing back toward the stock's 52-week high of $36.28 set on March 20, 2026. Primary catalyst: Continued momentum from a blockbuster Q4 fiscal 2026 earnings report delivered March 19, which sent revenue 41% higher year-over-year to $86.8 million, well above the $78 million Wall Street consensus.
ASTS shares surged approximately +11.00% in active intraday trading on March 25, 2026, moving from a prior close of $86.98 to approximately $96.55. The primary driver is a broad space sector rally fueled by renewed SpaceX IPO speculation, lifting satellite and space-related equities across the board.
FUBO shares are set to open about 12% lower in Wednesday’s premarket session after closing the prior day at roughly $12.02. The decline follows a strong multi-week rally powered by balance-sheet news, including the repurchase of $140.2 million of 2026 convertible notes and improving profitability trends.
One & One Green Technologies Inc. (YDDL) shares are indicated down about 13% in Wednesday’s premarket session after closing the prior regular session at $12.00. The stock had just surged 15.6% in the latest completed session, jumping from a prior close of $10.38 to $12.00, leaving it vulnerable to swift profit‑taking and volatility.
AVXL shares are indicated down about 33% in Wednesday’s premarket session, after closing the prior regular session at $4.19. The slide follows a recent drop triggered by a wider‑than‑expected fourth‑quarter loss and ongoing questions about the company’s late‑stage neurology pipeline.
AUGO shares are trading roughly 9% higher in Wednesday action, moving from a prior close of $66.42 to around $72.40 intraday. The stock’s advance extends a powerful year-long rally underpinned by record 2025 production, surging Adjusted EBITDA, and a recently declared cash dividend of $0.66 per share.
NAVN shares are surging approximately +25% in premarket trading on March 26, 2026, following a blockbuster earnings report released after the close of the prior session. Primary catalyst: Q4 fiscal year 2026 results delivered a significant beat — revenue of $178 million rose 35% year-over-year, surpassing analyst forecasts by nearly 10%.
OLPX surged approximately +50.38% in premarket trading on March 26, 2026, from a previous close of $1.33 to approximately $2.00, with an intraday premarket high of $2.03. The primary catalyst is a definitive acquisition agreement by German consumer goods giant Henkel AG to purchase Olaplex for $2.06 per share in an all-cash deal, valuing the company at approximately $1.4 billion.
TASK shares are down approximately -36% in premarket trading on March 26, 2026, the stock's official ex-dividend date for its special $3.65 per share cash dividend. The $3.65 special cash dividend — exceeding 25% of the stock's pre-ex-div market value — triggered a mandatory Nasdaq-prescribed price adjustment on today's open.
MLKN shares are down approximately 18.90% in premarket trading on March 26, 2026, falling to $15.70 from the prior session's close of $19.36. The primary catalyst is a double miss on both earnings and revenue in the company's fiscal Q3 2026 report released after the close on March 25.
Wave Life Sciences (WVE) shares are tumbling approximately 51% in premarket trading on March 26, 2026, from a prior close of $12.30 to approximately $6.03. The primary catalyst is the release of highly anticipated INLIGHT Phase 1 clinical data for WVE-007, the company's investigational INHBE GalNAc-siRNA obesity treatment, with results falling materially short of investor expectations.
APP is trading approximately 6% lower in premarket trading on March 26, 2026, extending a multi-session losing streak. The prior regular-session close (March 25, 2026) stood at $435.91, itself already down 5.02% from the day before, making the premarket slide a continuation of accelerating selling pressure.